How does the use of real-world evidence impact cancer drug approval?
The use of real-world evidence (RWE) has significantly impacted cancer drug approval by providing supplementary data on the effectiveness and safety of treatments outside of controlled clinical trials. RWE includes data collected from electronic health records, patient registries, and insurance claims. Regulatory agencies now consider RWE to make more informed decisions, potentially accelerating the approval process for new cancer therapies.
